US Patent Issued to SYNARC RESEARCH LABORATORY (BEIJING), HEBEI YANDA LU DAOPEI HOSPITAL on Dec. 9 for "Antibody combination for one-step screening and/or diagnosis of clonal diseases and related application" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,980, issued on Dec. 9, was assigned to SYNARC RESEARCH LABORATORY (BEIJING) LTD. (Beijing) and HEBEI YANDA LU DAOPEI HOSPITAL (Langfang, China).

"Antibody combination for one-step screening and/or diagnosis of clonal diseases and related application" was invented by Hui Wang (Beijing), Man Chen (Beijing), Aixian Wang (Beijing), Meiwei Gong (Beijing), Xueying Wu (Beijing), Junyi Zhen (Beijing), Qing Du (Beijing) and Ya Guo (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are an antibody combination for one-step screening and/or diagnosis of clonal diseases and application thereof. The antibody combination includes eight groups of anti...